Biology of graft-versus-host responses: recent insights
- PMID: 23290438
- PMCID: PMC3543773
- DOI: 10.1016/j.bbmt.2012.11.005
Biology of graft-versus-host responses: recent insights
Similar articles
-
[Graft vs. host disease and graft vs. leukemia/tumor effect].Nihon Rinsho. 2003 Sep;61(9):1484-7. Nihon Rinsho. 2003. PMID: 14515713 Review. Japanese. No abstract available.
-
Toward amplification of a graft-versus-leukemia effect while minimizing graft-versus-host disease.J Hematother Stem Cell Res. 2000 Jun;9(3):355-66. doi: 10.1089/15258160050079461. J Hematother Stem Cell Res. 2000. PMID: 10894357 Review. No abstract available.
-
[Allorecognition of the recipient after hematopoietic transplantation].Bull Cancer. 2003 Aug-Sep;90(8-9):706-10. Bull Cancer. 2003. PMID: 14609760 Review. French.
-
Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.Biol Blood Marrow Transplant. 2006 Apr;12(4):397-407. doi: 10.1016/j.bbmt.2005.11.519. Biol Blood Marrow Transplant. 2006. PMID: 16545723
-
Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.Biol Blood Marrow Transplant. 2004 Aug;10(8):540-51. doi: 10.1016/j.bbmt.2004.05.007. Biol Blood Marrow Transplant. 2004. PMID: 15282532
Cited by
-
Immune Modulation in Hematologic Malignancies.Semin Oncol. 2015 Aug;42(4):617-25. doi: 10.1053/j.seminoncol.2015.05.009. Epub 2015 Jun 3. Semin Oncol. 2015. PMID: 26320065 Free PMC article. Review.
-
Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment.Am J Clin Dermatol. 2018 Feb;19(1):33-50. doi: 10.1007/s40257-017-0306-9. Am J Clin Dermatol. 2018. PMID: 28656563 Free PMC article. Review.
-
Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease.Blood. 2020 Jan 2;135(1):28-40. doi: 10.1182/blood.2019000032. Blood. 2020. PMID: 31697815 Free PMC article.
-
Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response.J Clin Invest. 2017 Feb 1;127(2):517-529. doi: 10.1172/JCI86175. Epub 2017 Jan 9. J Clin Invest. 2017. PMID: 28067665 Free PMC article.
-
Mitochondrial Deacetylase SIRT3 Plays an Important Role in Donor T Cell Responses after Experimental Allogeneic Hematopoietic Transplantation.J Immunol. 2018 Dec 1;201(11):3443-3455. doi: 10.4049/jimmunol.1800148. Epub 2018 Nov 2. J Immunol. 2018. PMID: 30389773 Free PMC article.
References
-
- Matte CC, et al. Donor APCs are required for maximal GVHD but not for GVL. Nat Med. 2004;10(9):987–992. - PubMed
-
- Shlomchik WD, et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science. 1999;285(5426):412–415. - PubMed
-
- Teshima T, et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med. 2002;8(6):575–581. - PubMed
-
- Koyama M, et al. Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease. Nat Med. 2012;18(1):135–142. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources